Bitterman Robert J's Form 4 filing
Phio Pharmaceuticals Corp. (PHIO) · filed May 23, 2025
- Accession no.
- 0001062993-25-010155
- Filed
- May 23, 2025
- Trade date
- May 21-22, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $7.45K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bitterman Robert JCIK 0001304395 | Director, Officer (Chairman, Pres & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | Common Stock, $0.0001 par value | PPurchaseAcquired | +3,000 | $1.77 | +$5,310 | 22,449 | Direct | |
| May 22, 2025 | Common Stock, $0.0001 par value | PPurchaseAcquired | +1,200 | $1.78 | +$2,136 | 23,649 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.